Skanska USA Building Inc. v. Regeneron Pharmaceuticals Inc.

District Court, S.D. New York·Decided April 3, 2025·No. 7:23-cv-08418·Unknown

Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK SKANSKA USA BUILDING INC., Plaintiff, OPINION AND ORDER

-against- No. 23-CV-8418 (PMH) REGENERON PHARMACEUTICALS INC., and

SHAWN’S LAWNS INC., Defendants. PHILIP M. HALPERN, United States District Judge: Skanska USA Building Inc. (“Skanska” or “Plaintiff”) initiated this action against Regeneron Pharmaceuticals, Inc. (“Regeneron”) on September 22, 2023. (Doc. 1). Plaintiff filed a First Amended Complaint (Doc. 52, “FAC”) on July 29, 2024, which added Shawn’s Lawns Inc. (“SLI” and together with Regeneron, “Defendants”) as a defendant. On October 7, 2024, SLI filed an answer to the FAC with counterclaims. (Doc. 80). Thereafter, on November 12, 2024, SLI filed an amended answer to the FAC with counterclaims and crossclaims. (Doc. 86). On December 2, 2024, in accordance with the Court’s directive at the November 25, 2024 pre-motion conference, Plaintiff filed a Second Amended Complaint that eliminated certain disputed allegations that were subject of a motion to strike and otherwise did not change. (Doc. 89; Doc. 90, “SAC”). The Court directed Defendants to file an amended answer to the SAC that only eliminated their responses to the stricken allegations. (Doc. 89). On December 20, 2024, SLI filed its amended answer to the SAC that eliminated its responses to the stricken allegations and, based on the parties’ exchange of pre-motion letters, eliminated its crossclaim for fraudulent inducement and added a crossclaim for breach of oral agreement. (Doc. 91; Doc. 97, “First Amended Crossclaims”). SLI’s extant crossclaims against Regeneron, as of December 20, 2024, are for (1) breach of oral agreement and (2) unjust enrichment. (Id.). Regeneron, in accordance with the briefing schedule set by the Court, moved to dismiss SLI’s crossclaims under Federal Rule of Civil Procedure 12(b)(6) on February 11, 2025. (Doc. 119; Doc. 120, “Reg. Br.”; Doc. 123, “Ohring Decl.”). On February 18, 2025, SLI opposed the motion to dismiss (Doc. 122, “Steinvurzel Decl.”; Doc. 124; Doc. 125, “SLI Br.”) and filed, without leave of the Court, a cross-motion1 for leave to amend its answer to the SAC with

counterclaims and crossclaims pursuant to Federal Rule of Civil Procedure 15. (Doc. 118, “Second Amended Crossclaims”; Doc. 121). Regeneron, on February 25, 2025, filed its reply brief in support of its motion to dismiss and in opposition to SLI’s cross-motion for leave to amend. (Doc. 126, “Reply”).2 For the reasons set forth below, SLI’s cross-motion for leave to amend its answer with counterclaims and crossclaims is GRANTED. Regeneron’s motion to dismiss SLI’s crossclaims is GRANTED in part and DENIED in part.

BACKGROUND The Court assumes the parties’ familiarity with the procedural posture and factual allegations as laid out in its prior orders. (See, e.g., Docs. 42, 117). In March 2022, Regeneron and Skanska entered into a contract regarding new construction at Regeneron’s campus in Tarrytown, New York (the “Project”). (Second Amended Crossclaims ¶¶ 2, 7). Skanska thereafter hired SLI to work on the Project under three separate subcontracts. (Id.

1 SLI failed to first request a pre-motion conference pursuant to Rules 2(C) and 4(C) of this Court’s Individual Practices. Despite this procedural deficiency, the Court will, in the interest of judicial efficiency, consider SLI’s cross-motion for leave to amend its answer with counterclaims and crossclaims. 2 Citations to the parties’ filings correspond to the pagination generated by ECF. 2 ¶¶ 1, 31). SLI alleges that roughly $5,000,000 in retainage is presently being withheld by Regeneron in connection with these subcontracts. (Id. ¶ 46). By January 2024, Regeneron and Skanska began negotiating a closeout of Skanska’s work on the Project, including a transfer of SLI’s work from Skanska to the incoming construction

manager, Suffolk Construction (“Suffolk”). (Id. ¶ 48). SLI alleges that Regeneron, in anticipation Skanska’s termination, sought from SLI a proposal for its continued work on the Project “directly under Regeneron.” (Id. ¶ 78). SLI provided Regeneron a written proposal for such work on April 12, 2024, and negotiated the proposal “with both parties understanding that if Regeneron did not pay SLI the retainage that SLI would not perform further work.” (Id. ¶ 79). SLI’s final proposal to Regeneron was dated April 30, 2024. (Id. ¶ 80). Regeneron never countersigned the proposal. (Id. ¶ 82). SLI alleges, however, that Regeneron “agreed” that SLI would be paid $437,402 for the work outlined in the April 30 proposal (the “Additional Work”) and that SLI would be paid the retainage, and that Regeneron directed SLI to perform the Additional Work. (Id. ¶¶ 81-82). Accordingly, SLI alleges that an oral agreement existed for Regeneron’s payment “of the retainage

and of the $437,402” in exchange for SLI’s performance of the Additional Work. (Id. ¶¶ 83, 87). SLI performed the Additional Work. (Id. ¶ 84). Months later, Regeneron instructed Suffolk to add the Additional Work into the contract between Suffolk and SLI. (Id. ¶ 85). Suffolk did so and thereafter paid $437,402 to SLI. (Id.). Regeneron still has not paid SLI the retainage and, therefore, has allegedly breached the oral agreement. (Id. ¶ 86). This litigation followed. STANDARD OF REVIEW On a Rule 12(b)(6) motion, a court may dismiss a complaint for “failure to state a claim upon which relief can be granted.” Fed. R. Civ. P. 12(b)(6). “To survive a motion to dismiss, a 3 complaint must contain sufficient factual matter, accepted as true, to ‘state a claim to relief that is plausible on its face.’” Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009) (quoting Bell Atl. Corp. v. Twombly, 550 U.S. 544, 570 (2007)).3 A claim is plausible on its face “when the ple[d] factual content allows the court to draw the reasonable inference that the defendant is liable for the

misconduct alleged.” Id. (citing Twombly, 550 U.S. at 556). “The plausibility standard is not akin to a ‘probability requirement,’ but it asks for more than a sheer possibility that a defendant acted unlawfully.” Id. The factual allegations pled “must be enough to raise a right to relief above the speculative level.” Twombly, 550 U.S. at 555. “When there are well-ple[d] factual allegations, a court should assume their veracity and then determine whether they plausibly give rise to an entitlement to relief.” Iqbal, 556 U.S. at 679. Thus, the court must “take all well-ple[d] factual allegations as true, and all reasonable inferences are drawn and viewed in a light most favorable to the plaintiff[].” Leeds v. Meltz, 85 F.3d 51, 53 (2d Cir. 1996). The presumption of truth, however, “‘is inapplicable to legal conclusions,’ and ‘[t]hreadbare recitals of the elements of a cause of action, supported by mere conclusory

statements, do not suffice.’” Harris v. Mills, 572 F.3d 66, 72 (2d Cir. 2009) (quoting Iqbal, 556 U.S. at 678 (alteration in original)). Therefore, a plaintiff must provide “more than labels and conclusions” to show entitlement to relief. Twombly, 550 U.S. at 555. ANALYSIS I. Motion for Leave to Amend SLI argues that it was permitted to amend its pleading as of right under Rule 15(a)(1)(B) and, even if not, the Court should grant SLI leave to amend pursuant to Rule 15(a)(2).

Free access — add to your briefcase to read the full text and ask questions with AI

Skanska USA Building Inc. v. Regeneron Pharmaceuticals Inc., (S.D.N.Y. 2025).

Skanska USA Building Inc. v. Regeneron Pharmaceuticals Inc. (Skanska USA Building Inc. v. Regeneron Pharmaceuticals Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Foman v. Davis
371 U.S. 178 (Supreme Court, 1962)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
DiFolco v. MSNBC Cable L.L.C.
622 F.3d 104 (Second Circuit, 2010)
Harris v. Mills
572 F.3d 66 (Second Circuit, 2009)
Zeising v. Kelly
152 F. Supp. 2d 335 (S.D. New York, 2001)
Henry Heckman v. Town of Hempstead
568 F. App'x 41 (Second Circuit, 2014)
Baron v. Pfizer, Inc.
42 A.D.3d 627 (Appellate Division of the Supreme Court of New York, 2007)
Sybelle Carpet & Linoleum of Southampton, Inc. v. East End Collaborative, Inc.
167 A.D.2d 535 (Appellate Division of the Supreme Court of New York, 1990)
Sackin v. TransPerfect Global, Inc.
278 F. Supp. 3d 739 (S.D. New York, 2017)
Koenig v. Boulder Brands, Inc.
995 F. Supp. 2d 274 (S.D. New York, 2014)